Gene- and Cell-Based Therapies Entering Glaucoma Trials in April 2026
Some trials deliver genes encoding neuroprotective factors into the eye to help RGCs survive. For example, one approach uses a harmless viral vector...
Deep research and expert guides on maintaining your visual health.
Some trials deliver genes encoding neuroprotective factors into the eye to help RGCs survive. For example, one approach uses a harmless viral vector...
Cell therapy uses living cells as the treatment to repair, replace, or support damaged tissues and organs. Instead of giving a pill or surgery alone, doctors introduce cells that can become new tissue, secrete helpful factors, or change the immune response. Some cell therapies use a personโs own cells, which lowers the chance of rejection, while others use donor or engineered cells chosen for their special abilities. This approach matters because it has the potential to restore function in ways that traditional treatments cannot, such as replacing lost cells or regenerating damaged structures. Delivery methods vary: cells can be injected, placed on scaffolds, or guided to the right spot by minimally invasive tools. There are hurdles to overcome, including making sure the cells survive, behave correctly, and do not cause unwanted growths or immune reactions. Scientists are improving cell preparation, storage, and targeting to make therapies safer and more reliable. When successful, cell therapy can move care from managing symptoms toward actually healing the underlying problem.